- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Impaired Glucose Tolerance in South Africa
Total 900 results
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Canada, South Africa, Romania, Brazil, China, Ukraine
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Puerto Rico, United States, Romania, United Kingdom, Spain, Mexico, Austria, South Africa, Germany, Ukraine, India
-
PfizerCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States, Canada, Mexico, India, Puerto Rico, Russian Federation, South Africa
-
NuSirt BiopharmaCompletedType 2 Diabetes MellitusUnited States
-
NuSirt BiopharmaCompletedType 2 Diabetes MellitusUnited States
-
University of South CarolinaNational Institute of Nursing Research (NINR)RecruitingCardiovascular Diseases | Stroke | Diabetes Mellitus, Type 2 | Chronic Kidney Diseases | Chronic Disease | SARS- CoV-2United States
-
Synvista Therapeutics, IncJuvenile Diabetes Research FoundationTerminatedDiabetes Mellitus, Type 1 | Diabetic NephropathyAustralia, Denmark
-
Clínica Los YosesNovo Nordisk A/SCompletedDiabetes Mellitus, Type 2Costa Rica, El Salvador, Guatemala, Honduras
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Colombia, Mexico, Poland, Spain, India, Malaysia, Romania, South Africa, Sweden, Korea, Republic of, Estonia, Puerto Rico, Austria, Lithuania, Philippines, Guatemala, Iceland
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Russian Federation, Puerto Rico, United States, Australia, Hungary, Poland, Romania, Spain
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusItaly, Poland, Hungary, Mexico, Greece, Australia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Greece, India, Netherlands, Poland, Puerto Rico
-
Novo Nordisk A/SRecruitingDiabetes Mellitus, Type 2United States, Korea, Republic of, Australia, India, Canada, Japan, South Africa
-
University of Alabama at BirminghamRecruitingDiabetes Mellitus, Type 2 | Preterm Birth | Pregnancy, High Risk | Diabetes, GestationalUnited States
-
Novo Nordisk A/SRecruitingDiabetes, Type 2United States, India, Spain, Poland, South Africa, Bulgaria, Germany, Japan, Puerto Rico
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Australia, Canada, Denmark, Netherlands, Sweden
-
AstraZenecaTerminatedType 2 DiabetesItaly, Poland, South Africa, Norway, Belgium, Hungary, Slovakia, Taiwan, Philippines, Thailand, Mexico, Hong Kong, Malaysia
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Argentina, Poland, Germany, Bulgaria, Peru, Russian Federation, Mexico, Hungary, South Africa, Latvia, New Zealand, Costa Rica, India, Czechia, Romania, Lithuania, Puerto Rico, Chile
-
Sanford HealthUniversity of Exeter; The Leona M. and Harry B. Helmsley Charitable Trust; Pacific...RecruitingType 1 Diabetes | Celiac DiseaseUnited States
-
AstraZenecaQuintiles, Inc.CompletedType 2 DiabetesUnited States, Korea, Republic of, India, Russian Federation, Brazil, Mexico, South Africa, Philippines
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Spain, Hungary, Mexico, Slovakia, Greece, Argentina, South Africa, Australia
-
MedImmune LLCCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, France, Sweden, Poland, Turkey, Korea, Republic of, India, South Africa
-
Novo Nordisk A/SRecruitingDiabetes Mellitus, Type 2United States, Malaysia, United Kingdom, Australia, Netherlands, Portugal, Austria, Israel, India, Greece, Lebanon, Mexico, New Zealand, North Macedonia, Puerto Rico, Romania, Russian Federation, Ukraine, Morocco, Belgium, Czechia, Taiw...
-
Metabolic Solutions Development CompanyCompletedType 2 Diabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Israel, United Kingdom, Canada, Spain, Denmark, Austria, Serbia, South Africa, Sweden, Italy, Bulgaria, Germany, Malaysia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, United Kingdom, Mexico, Russian Federation, Japan, Canada, Italy, South Africa, Romania
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, Japan, Serbia, South Africa, China, Slovakia
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, France, Switzerland, Germany, South Africa, Korea, Republic of, Puerto Rico, Canada, Taiwan, Spain, Poland, Slovakia, Thailand, Mexico, Turkey, Australia, Greece, Norway, Sweden, Peru, Romania, Argentina, United Kingdom
-
Bionime CorporationNot yet recruiting
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Serbia, South Africa, Taiwan, Romania, Algeria, Hong Kong, Brazil, China, Czechia
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Greece, Korea, Republic of, Singapore
-
Mayo ClinicJohns Hopkins University; University of Chicago; Brigham and Women's Hospital; University... and other collaboratorsCompletedHypertension | Obesity | Diabetes Mellitus, Type 2United States
-
NovartisTerminatedDiabetes Mellitus, Type 2Germany, United Kingdom, Turkey, United States, Belgium, Japan, Korea, Republic of, Romania, Argentina, Peru, South Africa, India, China, Hungary
-
HealthInsightCenter for Technology and Aging; VoxivaUnknownType II Diabetes MellitusUnited States
-
Response PharmaceuticalsCompletedType 2 DiabetesUnited States
-
Response PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
TakedaCompletedDiabetes MellitusUnited States, Australia, Brazil, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Argentina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland, Spain, Sweden, Malaysia, France, Netherlands, India, Argentina, South Africa, Romania, Former Serbia and Montenegro, Austria, Czech Republic, Philippines, Mexico
-
Eli Lilly and CompanyTerminatedDiabetes Mellitus, Type 2United States, Puerto Rico, Germany, United Kingdom, Austria
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Israel, Russian Federation, United Kingdom, Taiwan, Argentina, Finland, Hungary, Macedonia, The Former Yugoslav Republic of, Malaysia, Mexico, Norway, Serbia, South Africa
-
TakedaCompletedDiabetes MellitusUnited States, Poland, Ukraine, Argentina, Israel, Mexico, Romania, Serbia, Australia, Brazil, New Zealand, Russian Federation, Chile, Hungary, Bulgaria, Lithuania, India, Latvia, Croatia, Slovakia, Guatemala, South Africa, Estonia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Italy, Spain, Austria, Finland, Hungary, Turkey, France, United Kingdom, Switzerland, Bulgaria, Germany, South Africa, Former Serbia and Montenegro
-
Mylan Inc.Mylan GmbHCompletedType 2 DiabetesUnited States, Jordan, Korea, Republic of, Slovakia, South Africa, Taiwan
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico
-
AstraZenecaCompletedType 2 DiabetesUnited States
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2France, United States, Mexico, United Kingdom, Spain, Canada, New Zealand, Thailand, Russian Federation, Brazil, Germany, Australia, Poland, Slovakia, Peru, Ukraine, South Africa, Costa Rica, Puerto Rico
-
TakedaCompletedType 2 Diabetes MellitusUnited States, Australia, Brazil, Bulgaria, Chile, Croatia, Estonia, Guatemala, India, Israel, Latvia, Mexico, New Zealand, Peru, Romania, Russian Federation, Serbia, South Africa, Ukraine